Narrow your search

Library

KU Leuven (4)

UNamur (3)

UAntwerpen (2)

ULiège (2)

LUCA School of Arts (1)

Odisee (1)

Thomas More Kempen (1)

Thomas More Mechelen (1)

UCLouvain (1)

UCLL (1)

More...

Resource type

book (4)


Language

English (4)


Year
From To Submit

2010 (1)

1984 (1)

1982 (1)

1981 (1)

Listing 1 - 4 of 4
Sort by
Cardiovascular drugs and the management of heart disease
Authors: ---
ISBN: 0890045682 9780890045688 Year: 1982 Publisher: New York (N.Y.): Raven Press,

Calcium entry blockers in cardiovascular and cerebral dysfunctions
Author:
ISBN: 0898386586 9400960352 9400960336 9780898386585 Year: 1984 Volume: 40 Publisher: Boston: Nijhoff,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Keywords

Neuropathology --- Pathology of the circulatory system --- Calcium Channel Blockers --- Cardiovascular Diseases --- Hypertension --- Cerebrovascular Disorders --- Calcium --- Cardiovascular system --- Cerebrovascular disease --- pharmacology --- drug therapy --- Antagonists --- Therapeutic use --- Diseases --- Chemotherapy --- -Cardiovascular system --- -Cerebrovascular disease --- -Apoplexy --- Brain --- Cerebral circulation disorders --- Cerebral vascular accident --- Cerebrovascular accident --- Cerebrovascular disorders --- Cerebrovascular syndrome --- CVA (Disease) --- Stroke --- Neglect (Neurology) --- Circulatory system --- Vascular system --- Blood --- Alkaline earth metals --- High-calcium diet --- pharmacology. --- therapeutic use. --- drug therapy. --- -Therapeutic use --- -Chemotherapy --- Blood-vessels --- Circulation --- CALCIUM CHANNEL BLOCKERS --- CALCIUM CHANNEL BLOCKERS, therapeutic use --- CARDIOVASCULAR DISEASES, drug therapy --- CEREBROVASCULAR DISORDERS, drug therapy --- HYPERTENSION --- Therapeutic use. --- Chemotherapy. --- pharmacodynamics. --- -pharmacology. --- CALCIUM CHANNEL BLOCKERS, therapeutic use. --- CARDIOVASCULAR DISEASES, drug therapy. --- CEREBROVASCULAR DISORDERS, drug therapy. --- Calcium channel blockers --- Calcium channel blockers, therapeutic use. --- Cardiovascular diseases, drug therapy. --- Cerebrovascular disorders, drug therapy. --- Cardiovascular diseases --- Pharmacology. --- Pharmacodynamics. --- Drug therapy. --- Apoplexy --- Antagonists&delete& --- Diseases&delete& --- therapeutic use --- Calcium Channel Blockers - pharmacology --- Cardiovascular Diseases - drug therapy --- Hypertension - drug therapy --- Cerebrovascular Disorders - drug therapy --- Calcium - Antagonists - Therapeutic use --- Cardiovascular system - Diseases - Chemotherapy --- Cerebrovascular disease - Chemotherapy


Book
Antithrombotic drug therapy in cardiovascular disease
Authors: ---
ISBN: 1607613468 1603272348 9786612828171 1603272356 1627037977 1282828177 Year: 2010 Publisher: Dordrecht ; New York : Humana Press,

Loading...
Export citation

Choose an application

Bookmark

Abstract

Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).

Listing 1 - 4 of 4
Sort by